[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lantern Pharma Inc (LTRN)

Lantern Pharma Inc (LTRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 33,556
  • Shares Outstanding, K 12,759
  • Annual Sales, $ 0 K
  • Annual Income, $ -17,120 K
  • EBIT $ -17 M
  • EBITDA $ -17 M
  • 60-Month Beta 2.30
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 8.23

Options Overview Details

View History
  • Implied Volatility 696.38% (+208.32%)
  • Historical Volatility 83.84%
  • IV Percentile 93%
  • IV Rank 79.30%
  • IV High 857.88% on 02/18/26
  • IV Low 77.80% on 01/30/26
  • Expected Move (DTE 20) 0.13 (4.85%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 15
  • Volume Avg (30-Day) 25
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 487
  • Open Int (30-Day) 578
  • Expected Range 2.50 to 2.76

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-0.54
  • Growth Rate Est. (year over year) +185,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.51 +4.78%
on 07/30/26
4.34 -39.40%
on 07/01/26
-1.54 (-36.93%)
since 06/30/26
3-Month
1.96 +34.18%
on 05/01/26
4.34 -39.40%
on 07/01/26
+0.58 (+28.29%)
since 04/30/26
52-Week
1.11 +136.94%
on 03/27/26
5.74 -54.21%
on 08/06/25
-1.38 (-34.41%)
since 07/30/25

Most Recent Stories

More News
Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer

Investigator-initiated European study will evaluate a distinctive dual-biomarker precision-oncology strategy — PTGR1 overexpression combined with tumor-specific Nucleotide Excision Repair — in patients...

LTRN : 2.63 (-0.75%)
New to The Street to Broadcast Nationwide on Bloomberg Television Tonight at 6:30 PM ET Featuring RHINO Bitcoin, Marina Decisions, Medicus Pharma and Virtuix Holdings

NEW YORK CITY, NY / ACCESS Newswire / July 25, 2026 / New to The Street, one of America's longest-running sponsored business television brands, today announced the broadcast of its latest episode, airing...

CAST : 1.2300 (-6.82%)
RHNO : 7.2500 (+3.57%)
PETV : 0.6890 (+7.66%)
VTIX : 1.5700 (-2.48%)
LTRN : 2.63 (-0.75%)
MDCX : 0.2752 (+4.80%)
BSIN : 1.1400 (+1.79%)
DVLT : 0.3402 (-2.27%)
COCH : 0.6706 (+0.62%)
Lantern Pharma Receives USPTO Notice of Allowance for Patent Covering Biomarker-Guided Treatment with LP-184 (Zirdafulven) in Multiple Solid Tumor Cancers

Allowed patent claims cover the use of a three-gene expression signature — PTGR1, PTPN14, and ASPH — to identify patients for treatment with LP-184 (Zirdafulven) ...

LTRN : 2.63 (-0.75%)
New to The Street(R) to Broadcast Show #762 Tonight on Bloomberg Television at 6:30 PM ET, Featuring Envoy Medical (NASDAQ:COCH), AlphaCompute (NASDAQ:ALP), RHINO Bitcoin (OTC PINK:RHNO), and Big Sky Industrial (NASDAQ:BSIN)

Sponsored Programming Airs Across Bloomberg Television U.S., MENA, and Latin America, Supported by Television Commercials From Lantern Pharma, Datavault AI, Big Sky Industrial, FreeCast, PetVivo Holdings,...

CAST : 1.2300 (-6.82%)
RHNO : 7.2500 (+3.57%)
PETV : 0.6890 (+7.66%)
IGC : 0.2490 (-0.20%)
ALP : 0.1963 (-1.36%)
LTRN : 2.63 (-0.75%)
BSIN : 1.1400 (+1.79%)
DVLT : 0.3402 (-2.27%)
COCH : 0.6706 (+0.62%)
New to The Street Show #761 to Broadcast Across Bloomberg U.S., Latin America and MENA, Featuring Sagtec Global, Virtuix, Lantern Pharma and YY Group

The show broadcasts at 6:30 PM ET as sponsored programming, with television commercials featuring Big Sky Industrial, Envoy Medical, FreeCast and Datavault AI

CAST : 1.2300 (-6.82%)
VTIX : 1.5700 (-2.48%)
LTRN : 2.63 (-0.75%)
YYGH : 1.2000 (-4.00%)
BSIN : 1.1400 (+1.79%)
DVLT : 0.3402 (-2.27%)
SAGT : 0.7700 (-10.68%)
COCH : 0.6706 (+0.62%)
Lantern Pharma Launches ZetaOmics™ — an Autonomous, Intelligent “Computational Biologist” That Brings Expert-Grade Bioinformatics, Biostatistics & Reasoning to Every Cancer

First previewed in the company’s May roadmap, the new withZeta.ai module now enters early access with leading bioinformatics teams and Lantern collaborators — autonomously designing experiments, building...

LTRN : 2.63 (-0.75%)
New to The Street Show #760 Airs Tonight on Bloomberg Television Across the U.S. on Independence Day Featuring Sullivan & Cromwell’s Frank Aquila, Medicus Pharma, PetVivo, FreeCast and YY Group

Honoring Economic Freedom and American Capitalism Through Television That Connects Markets, Entrepreneurs, and Investors

CAST : 1.2300 (-6.82%)
PETV : 0.6890 (+7.66%)
LTRN : 2.63 (-0.75%)
MDCX : 0.2752 (+4.80%)
YYGH : 1.2000 (-4.00%)
BSIN : 1.1400 (+1.79%)
DVLT : 0.3402 (-2.27%)
New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.

FreeCast (NASDAQ:CAST), Big Sky Industrial (NASDAQ:BSIN), Virtuix Holdings (NASDAQ:VTIX), and Marco Polo Exchange's Steve Carlson Featuring Argentina's Capital Markets Highlight This Week's National Broadcast...

CAST : 1.2300 (-6.82%)
RDZN : 1.1500 (-1.29%)
VTIX : 1.5700 (-2.48%)
LTRN : 2.63 (-0.75%)
NRXP : 3.15 (+0.96%)
BSIN : 1.1400 (+1.79%)
DVLT : 0.3402 (-2.27%)
COCH : 0.6706 (+0.62%)
New to The Street Broadcasts Tonight on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM ET

Featured Interviews Include Envoy Medical (NASDAQ:COCH), Big Sky Industrial (NASDAQ:BSIN), Graphene Manufacturing Group (OTCQX:GMGMF), Gold Royalty Corp. (NYSE American:GROY), and New York City's Acclaimed...

RDZN : 1.1500 (-1.29%)
CAST : 1.2300 (-6.82%)
GROY : 2.60 (-3.35%)
GMGMF : 1.3750 (-2.48%)
LTRN : 2.63 (-0.75%)
MDCX : 0.2752 (+4.80%)
BSIN : 1.1400 (+1.79%)
DVLT : 0.3402 (-2.27%)
COCH : 0.6706 (+0.62%)
Lantern Pharma Reports HARMONIC™ Data Showing LP-300 Progression-Free Survival Benefit Deepens with Treatment Duration in EGFR Exon 21 L858R Lung Cancer

Exon 21 L858R NSCLC Mutated Patients Treated Through Up to Six Cycles Reached 8.9-Month Median PFS; Durable Responses Beyond Two Years; and a Consistently Clean Safety Profile. ...

LTRN : 2.63 (-0.75%)

Business Summary

Lantern Pharma Inc.is a biotechnology company. It develops medicines for multi-drug treatment resistance cancers focusing on prostate and ovarian cancers. The company's drug candidate consist LP-100, LP-300 and LP-184 which are in clinical stage. Lantern Pharma Inc.is based in Dallas, Texas.

See More

Key Turning Points

3rd Resistance Point 3.11
2nd Resistance Point 2.99
1st Resistance Point 2.81
Last Price 2.63
1st Support Level 2.51
2nd Support Level 2.39
3rd Support Level 2.21

See More

52-Week High 5.74
Fibonacci 61.8% 3.97
Fibonacci 50% 3.43
Fibonacci 38.2% 2.88
Last Price 2.63
52-Week Low 1.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.